Does TRANDOLAPRIL Cause Mobility decreased? 12 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Mobility decreased have been filed in association with TRANDOLAPRIL (Trandolapril). This represents 1.9% of all adverse event reports for TRANDOLAPRIL.
12
Reports of Mobility decreased with TRANDOLAPRIL
1.9%
of all TRANDOLAPRIL reports
0
Deaths
12
Hospitalizations
How Dangerous Is Mobility decreased From TRANDOLAPRIL?
Of the 12 reports, 12 (100.0%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRANDOLAPRIL. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does TRANDOLAPRIL Cause?
Dyspnoea (87)
Psychotic disorder (81)
Cough (76)
Fatigue (60)
Pneumonia (58)
Hypertension (57)
Asthma (56)
Hypotension (48)
Hallucination, auditory (46)
Paranoia (46)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which TRANDOLAPRIL Alternatives Have Lower Mobility decreased Risk?
TRANDOLAPRIL vs TRANDOLAPRIL\VERAPAMIL
TRANDOLAPRIL vs TRANEXAMIC ACID
TRANDOLAPRIL vs TRANYLCYPROMINE
TRANDOLAPRIL vs TRASTUZUMAB
TRANDOLAPRIL vs TRASTUZUMAB-ANNS